ASBPW

Aspire Biopharma Holdings, Inc. Warrant

35 hedge funds and large institutions have $823K invested in Aspire Biopharma Holdings, Inc. Warrant in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
-4
Holders Change %
-10.26%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
2
Closed
4
Calls
$2.22M
Puts
Net Calls
+$2.22M
Net Calls Change
-$143K
Name Holding Trade Value Shares
Change
Shares
Change %
AC
1
Athos Capital
Hong Kong
$233K
PC
2
Periscope Capital
Ontario, Canada
$87.7K
SCM
3
Saba Capital Management
New York
$63.9K
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$63K
LA
5
Linden Advisors
New York
$58.5K
HCM
6
Highbridge Capital Management
New York
$45K -$27.4K
AA
7
AQR Arbitrage
Connecticut
$38.9K
SC
8
Sculptor Capital
New York
$32.5K
Verition Fund Management
9
Verition Fund Management
Connecticut
$26K
WAM
10
Wolverine Asset Management
Illinois
$24.1K
Barclays
11
Barclays
United Kingdom
$21K
TCA
12
Taconic Capital Advisors
New York
$18K
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$12K
SFM
14
Spartan Fund Management
Canada
$11.2K
CCM
15
Context Capital Management
California
$10.5K
Nomura Holdings
16
Nomura Holdings
Japan
$9.08K
PAMP
17
Polar Asset Management Partners
Ontario, Canada
$8.31K
LP
18
LMR Partners
United Kingdom
$7.5K
WA
19
Whitebox Advisors
Minnesota
$7.5K
KL
20
KIM LLC
Kansas
$6K
JPMorgan Chase & Co
21
JPMorgan Chase & Co
New York
$6K
FSI
22
Flow State Investments
Illinois
$6K +$230 +3,832 +4%
CCM
23
CAAS Capital Management
New York
$4.5K
CS
24
Clear Street
New York
$3.19K -$84 -1,400 -3%
ACM
25
Atalaya Capital Management
New York
$3K